Thrombolytic treatment for recurrent myocardial infarction.
作者信息
White H
出版信息
BMJ. 1991 Feb 23;302(6774):429-30. doi: 10.1136/bmj.302.6774.429.
Abstract
摘要
相似文献
1
Thrombolytic treatment for recurrent myocardial infarction.复发性心肌梗死的溶栓治疗。
BMJ. 1991 Feb 23;302(6774):429-30. doi: 10.1136/bmj.302.6774.429.
2
Battle of the clotbusters.溶栓药物之战
BMJ. 1991 May 25;302(6787):1259-61. doi: 10.1136/bmj.302.6787.1259.
3
What you should know about thrombolytic therapy for acute MI.关于急性心肌梗死溶栓治疗你应该了解的内容。
Am J Nurs. 1993 Sep;93(9):24-31; quiz 33.
4
Thrombolytic therapy in acute myocardial infarction.急性心肌梗死的溶栓治疗
Am Fam Physician. 1992 Feb;45(2):640-8.
5
Intravenous thrombolytic therapy in myocardial infarction: an analytical review.
Clin Cardiol. 1993 Apr;16(4):283-92. doi: 10.1002/clc.4960160402.
6
Are the various thrombolytic agents equally effective in the treatment of acute transmural myocardial infarction?
Jpn Heart J. 1992 Jul;33(4):413-21. doi: 10.1536/ihj.33.413.
7
Effects of early thrombolytic therapy (anistreplase versus streptokinase) on enzymatic and electrocardiographic infarct size in acute myocardial infarction. TEAM-2 Investigators.
Am J Cardiol. 1991 Oct 1;68(9):848-56. doi: 10.1016/0002-9149(91)90398-5.
8
Thrombolytic therapy for acute myocardial infarction. Are inclusion criteria too stringent?急性心肌梗死的溶栓治疗。纳入标准是否过于严格？
Postgrad Med. 1994 Mar;95(4):77-82.
9
Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study Investigators.急性心肌梗死中静脉注射茴香酰化纤溶酶原链激酶激活剂复合物与链激酶的多中心通畅性试验。TEAM - 2研究调查人员。
Circulation. 1991 Jan;83(1):126-40. doi: 10.1161/01.cir.83.1.126.
10
Which thrombolytic agent should one choose?
Prog Cardiovasc Dis. 1991 Nov-Dec;34(3):165-78. doi: 10.1016/0033-0620(91)90011-a.
引用本文的文献
1
Pharmacoeconomic aspects of treatment of acute myocardial infarction with thrombolytic agents.溶栓药物治疗急性心肌梗死的药物经济学方面
Pharmacoeconomics. 1993 Mar;3(3):192-204. doi: 10.2165/00019053-199303030-00003.
2
Comparative tolerability profiles of thrombolytic agents. A review.溶栓药物的耐受性比较概况。综述。
Drug Saf. 1993 Jan;8(1):19-29. doi: 10.2165/00002018-199308010-00004.
3
Streptokinase. A review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients.链激酶。老年患者急性心肌梗死中其药理学及治疗效果的综述
Drugs Aging. 1994 Jan;4(1):63-86. doi: 10.2165/00002512-199404010-00007.
4
Thrombolytic treatment for recurrent myocardial infarction.复发性心肌梗死的溶栓治疗。
BMJ. 1991 Mar 30;302(6779):786. doi: 10.1136/bmj.302.6779.786.
5
Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.急性心肌梗死患者对静脉注射链激酶的免疫球蛋白反应。
Br Heart J. 1992 May;67(5):419. doi: 10.1136/hrt.67.5.419-a.
本文引用的文献
1
Assessment of anti-streptokinase antibody levels in human sera using a microradioimmunoassay procedure.采用微量放射免疫分析程序评估人血清中的抗链激酶抗体水平。
Thromb Haemost. 1984 Dec 29;52(3):281-7.
2
Thrombolytic therapy with streptokinase using a standard dosage scheme.采用标准剂量方案的链激酶溶栓治疗。
Br Med J. 1966 Feb 19;1(5485):454-6. doi: 10.1136/bmj.1.5485.454.
3
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.心肌梗死溶栓治疗（TIMI）试验，I期：静脉注射组织型纤溶酶原激活剂与静脉注射链激酶的比较。直至出院的临床结果。
Circulation. 1987 Jul;76(1):142-54. doi: 10.1161/01.cir.76.1.142.
4
Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction.首次心肌梗死后静脉注射链激酶与组织型纤溶酶原激活剂对左心室功能影响的比较
N Engl J Med. 1989 Mar 30;320(13):817-21. doi: 10.1056/NEJM198903303201301.
5
Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction.急性心肌梗死后重复溶栓治疗的安全性和有效性。
Br Heart J. 1990 Sep;64(3):177-81. doi: 10.1136/hrt.64.3.177.
6
Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking.
J Am Coll Cardiol. 1990 Aug;16(2):340-8. doi: 10.1016/0735-1097(90)90583-b.
7
GISSI-2 and the heparin controversy.
Lancet. 1990 Aug 4;336(8710):297-8. doi: 10.1016/0140-6736(90)91818-u.
8
Antistreptokinase titres after intravenous streptokinase.
Lancet. 1990 Jan 27;335(8683):184-5. doi: 10.1016/0140-6736(90)90276-b.
Zotero 插件